# Clustering Approach 4 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00380158418236354	Range of duration = 0.03 to 223.96, nDeath = 60, nCensor = 134
2	AGE	ANOVA	0.0274013207130031	Range of values = 40 to 86, Mean = 65.3402, StdDev = 9.82002, nMissing = 28
3	GENDER	Fisher's exact test	0.189349071966563	nTypes = 2 (FEMALE/MALE), nPatients = 120/102
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.601905847957853	Range of values = 0 to 100, Mean = 72.1053, StdDev = 33.5955, nMissing = 203
5	HISTOLOGICAL.TYPE	Chi-square test	0.102325279967228	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 6/50/134/3/10/1/2/2/9/1/4
6	PATHOLOGY.T	Chi-square test	0.615619719784242	nTypes = 4 (T1/T2/T3/T4), nPatients = 63/127/17/13, nMissing = 2
7	PATHOLOGY.N	Chi-square test	0.323665320991086	nTypes = 3 (N0/N1/N2+N3), nPatients = 131/44/42, nMissing = 5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.590912100980038	nTypes = 3 (M0/M1/MX), nPatients = 141/10/65, nMissing = 6
9	TUMOR.STAGE	Chi-square test	0.575759725418056	nTypes = 4 (I/II/III/IV), nPatients = 112/47/47/11, nMissing = 5
10	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0949266478980114	nTypes = 2 (NO/YES), nPatients = 15/207
11	NEOADJUVANT.THERAPY	Fisher's exact test	0.858645318259618	nTypes = 2 (NO/YES), nPatients = 32/190